Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Taohong Siwu Decoction exerts anticancer effects on breast cancer via regulating MYC , BIRC5 , EGF and PIK3R1 revealed by HTS 2 technology. Local targets link to admitted publications; unresolved targets remain external evidence.
Global Trend of Breast Cancer Mortality Rate: A 25-Year Study
10.31557/apjcp.2019.20.7.2015 · 2019 · External reference
10.1007/s12094-019-02187-8
10.1007/s12094-019-02187-8 · External reference
10.1016/j.trecan.2017.09.001
10.1016/j.trecan.2017.09.001 · External reference
The advantages of using traditional Chinese medicine as an adjunctive therapy in the whole course of cancer treatment instead of only terminal stage of cancer
10.5582/bst.2015.01019 · 2015 · External reference
UPLC-Q-TOF-MS Study of the Mechanism of THSWD for Breast Cancer Treatment
10.3389/fphar.2019.01625 · 2020 · External reference
Effect of Tao Hong Siwu Decoction on Angiogenesis in Patients with Breast cancer (in Chinese)
2012 · External reference
Effects of Taohong Siwu Decoction on Protein Expression of Bcl-2, Bax, and Ki-67 in Invasive Breast Cancer (in Chinese)
2018 · External reference
High-Throughput Strategies for the Discovery of Anticancer Drugs by Targeting Transcriptional Reprogramming
10.3389/fonc.2021.762023 · 2021 · External reference
10.1007/s13238-018-0533-8
10.1007/s13238-018-0533-8 · External reference
A large-scale transcriptional study reveals inhibition of COVID-19 related cytokine storm by traditional Chinese medicines
10.1016/j.scib.2021.01.005 · 2021 · External reference
10.1016/j.csbj.2020.05.004
10.1016/j.csbj.2020.05.004 · External reference
10.1073/pnas.1200305109
10.1073/pnas.1200305109 · External reference
Science, medicine, and the future: Bioinformatics
10.1136/bmj.324.7344.1018 · 2002 · External reference
Systems Pharmacology for Investigation of the Mechanisms of Action of Traditional Chinese Medicine in Drug Discovery
10.3389/fphar.2019.00743 · 2019 · External reference
TCMSP: a database of systems pharmacology for drug discovery from herbal medicines
10.1186/1758-2946-6-13 · 2014 · External reference
10.1093/nar/gks1100
10.1093/nar/gks1100 · External reference
SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules
10.1093/nar/gkz382 · 2019 · External reference
10.1093/nar/gku1205
10.1093/nar/gku1205 · External reference
10.1093/nar/gkx1037
10.1093/nar/gkx1037 · External reference
Therapeutic target database 2020: enriched resource for facilitating research and early development of targeted therapeutics
2020 · External reference
10.1186/s13059-014-0550-8
10.1186/s13059-014-0550-8 · External reference
10.1007/978-3-319-24277-4
10.1007/978-3-319-24277-4 · External reference
10.1073/pnas.0506580102
10.1073/pnas.0506580102 · External reference
10.1093/nar/gkg034
10.1093/nar/gkg034 · External reference
10.1101/gr.1239303
10.1101/gr.1239303 · External reference
10.1093/nar/gkm415
10.1093/nar/gkm415 · External reference
10.1038/ng.2764
10.1038/ng.2764 · External reference
10.1038/ng.2653
10.1038/ng.2653 · External reference
10.1093/nar/28.1.235
10.1093/nar/28.1.235 · External reference
10.1158/0008-5472.can-14-0305
10.1158/0008-5472.can-14-0305 · External reference
10.1038/nature09504
10.1038/nature09504 · External reference
10.1074/jbc.m212390200
10.1074/jbc.m212390200 · External reference
10.1016/j.cell.2011.02.013
10.1016/j.cell.2011.02.013 · External reference
Traditional Chinese Medicine for adjuvant treatment of breast cancer: Taohong Siwu Decoction
10.1186/s13020-021-00539-7 · 2021 · External reference
10.1002/mco2.68
10.1002/mco2.68 · External reference
10.1016/j.bbagrm.2014.03.013
10.1016/j.bbagrm.2014.03.013 · External reference
c-Myc Overexpression Promotes Oral Cancer Cell Proliferation and Migration by Enhancing Glutaminase and Glutamine Synthetase Activity
10.1016/j.amjms.2019.05.014 · 2019 · External reference
Cancer therapeutics using survivin BIRC5 as a target: what can we do after over two decades of study?
10.1186/s13046-019-1362-1 · 2019 · External reference
10.1016/j.pharmthera.2008.11.008
10.1016/j.pharmthera.2008.11.008 · External reference
10.1016/j.trecan.2019.02.009
10.1016/j.trecan.2019.02.009 · External reference
10.1186/s13058-019-1155-7
10.1186/s13058-019-1155-7 · External reference
10.1091/mbc.e09-05-0380
10.1091/mbc.e09-05-0380 · External reference
